RecruitMe Clinical Trial
L-DOPA vs. Placebo for Depression and Psychomotor Slowing in Older Adults
L-DOPA vs. Placebo for Depression and Psychomotor Slowing in Older Adults
| Sponsor: | NIMH National Institute of Mental Health |
| Enrolling: | Male and Female Patients |
| Study Length: | 8 Weeks |
| Clinic Visits: | 10 |
| Age Range: | Between 60 and 110 years old |
| IRB Number: | 7733 |
| U.S. Government ID: | NCT03761030 |
| Contact: | Marika Chrisanthopoulos: 646-774-8677 / marika.chrisanthopoulos@nyspi.columbia.edu |
Additional Study Information:
In this research study, you will receive a medication called carbidopa/levodopa (Sinemet). This medication is approved by the Food and Drug Administration for the treatment of Parkinson's Disease. We are using carbidopa/levodopa off-label in this study to see whether it is capable of improving depressive symptoms as well as mental and physical slowing that occur as people age.
